Systematic review of 34 placebo-controlled hereditary ataxia trials (those with variance data meta-analysed) found a measurable placebo effect on SARA scores, largest in Asian trials (-0.85) and device trials (-0.84), minimal in European trials.
Meta-analysisn = 34 trials
Petit et al. Quantifying Placebo Effects in Hereditary Ataxia Trials: A Meta-Analysis of Scale for the Assessment and Rating of Ataxia (SARA) Score Changes